adMare BioInnovations

Vancouver, BC
SeedSeries ASeries B+EarlyCVCA Member Directory 2026

Investment Thesis

adMare is Canada's life sciences company creation engine, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale across therapeutics modalities. The fund partners with innovators and entrepreneurs to overcome early-stage hurdles through early-stage capital, scientific expertise, turnkey lab facilities, and talent development programs, operating nationally across Canada's life sciences hubs.

Focus Areas

Investment Stage
SeedSeries ASeries B+Early
Sectors
Life SciencesBiotechnologyHealthcare

Investment Signals

GeographyCanada-focused
ProvincesBC, ON, QC
RoleLead
Revenue Stagepre-revenue ok
Impact MandateYes
Business Modelsdeep-tech, IP-licensing

Sample Portfolio Companies

Abdera
26therapeutics
Bright Angel Therapeutics
Epitopea
Evolved Therapeutics
Find Therapeutics
Immugenia

AUM & Sources

N/A
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →

Similar Funds

Quark Venture Inc.
Vancouver, BC
SeedSeries A
BDC Life Sciences Venture Fund
Canada
SeedSeries A
Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, Germany
SeedSeries A
AllosteRx Capital Management (Canada) Inc.
Montreal, QC
EarlySeed

See incorrect information?

Help us keep this directory accurate and up to date.